For decades, fish oil has been widely recommended for heart health. More recently, it has gained attention for its potential cognitive benefits, with many adults taking omega-3 supplements to support memory. Yet emerging research suggests that when it comes to the brain, not all omega-3 formulations perform equally.
While traditional fish oil provides EPA and DHA in triglyceride form, newer science indicates that the delivery method may play a critical role in whether those fatty acids effectively reach brain tissue. As understanding of the blood-brain barrier and lipid transport mechanisms advances, experts are beginning to ask an important question: Why might conventional fish oil not be enough for optimal brain health?
The Role of Omega-3s in Brain Function
Omega-3 fatty acids, particularly docosahexaenoic acid (DHA), are structural components of neuronal membranes. DHA helps maintain membrane fluidity, supports synaptic signaling, and plays a role in neuroplasticity. Eicosapentaenoic acid (EPA), while less concentrated in brain tissue, contributes to inflammation regulation and mood balance.
Dr. Barry Sears, a biochemist known for his work on fatty acid metabolism, emphasizes the importance of omega-3s, stating, “If you have only 15 seconds per day to improve your health, guzzle as many omega-3 fatty acids as you can in those 15 seconds.” He further explains their biological role: “Omega-3 fatty acids are the building blocks for hormones that resolve existing inflammation.”
Dr. Sears has suggested that many Americans fall short of adequate intake, largely due to high consumption of omega-6 fatty acids from processed foods. He recommends a minimum of 3 grams daily of EPA and DHA from high-quality sources to optimize heart, brain, and cellular health across the lifespan. However, increasing intake alone does not guarantee that omega-3s will effectively reach the brain.
The Bioavailability Challenge With Traditional Fish Oil
Most standard fish oil supplements deliver EPA and DHA in triglyceride form. After ingestion, these fats must be digested, absorbed in the intestine, reassembled, and transported through the circulation. Only a portion ultimately crosses the blood-brain barrier. A highly selective membrane designed to protect the brain from potentially harmful substances. Research has identified a specific transporter, known as Mfsd2A, that plays a key role in transporting DHA into the brain. Importantly, this transporter preferentially carries DHA when it is bound to lysophosphatidylcholine (LPC), not when it is in triglyceride form. This distinction has significant implications. If traditional fish oil does not efficiently utilize this transporter pathway, higher doses may not necessarily translate into higher brain DHA levels.
The Emergence of LPC-Bound Omega-3s
Advancements in lipid science have led to the development of LPC-bound omega-3 formulations designed to take advantage of the Mfsd2A transporter. These products aim to enhance direct transport across the blood-brain barrier by delivering EPA and DHA in lysophosphatidylcholine form. Fenix Health Science has introduced LYSOVETA®, an advanced omega-3 formulation featuring LPC-bound EPA and DHA derived from krill oil. According to published data from the company and its development partners, this form may offer up to six times better absorption into brain tissue compared to traditional triglyceride-based fish oil. More information about the science behind this formulation can be found at fenixhealthscience.com.
Developed in collaboration with Aker BioMarine, LYSOVETA® is one of the first commercially available LPC-bound omega-3 ingredients, with initial product launches in late 2024. In 2025, it was recognized as the #2 Best Ingredient in Healthy Aging at the NIE Awards, reflecting growing interest in targeted brain-delivery systems.
A Closer Look at Fenix Health Science’s Product Line
Fenix Health Science has incorporated LYSOVETA® into several consumer formulations under its Accentrate® Omega line. Accentrate® Omega is designed for children under 110 pounds and focuses on supporting attention, memory, and mood during key developmental years.
Accentrate® Omega 110, on the other hand, adjusts dosing for teens and adults over 110 pounds, maintaining similar cognitive and mood support benefits.
A higher-potency option is the Accentrate® Omega Max, intended for individuals seeking maximum brain support. This tiered structure allows for age- and weight-appropriate dosing, which may be particularly relevant for families, working adults under cognitive stress, and aging individuals concerned about maintaining mental sharpness. Fenix Health Science positions its products around bioavailability science rather than megadosing by focusing on delivery efficiency rather than simply increasing dosage.
Addressing the Omega-3 Debate
While omega-3s are widely studied, discussion continues regarding optimal dosing and safety. Dr. Paul Saladino, a psychiatrist and critic of excessive supplementation, has stated, “I don’t think excess amounts of omega-3 are a very good idea for any humans at all,” referencing research that has associated high doses around 4 grams per day with potential atrial fibrillation risk in some populations. He also highlights concerns regarding oxidation in poorly manufactured fish oils. These critiques underscore two important points: quality and dosage matter.
Advanced delivery systems like LPC-bound formulations may offer the potential for improved brain uptake without necessarily requiring very high daily doses. As with any supplement, patients should discuss individualized recommendations with their healthcare provider, particularly if managing cardiovascular conditions or taking prescription medications.
Who May Benefit From Advanced Brain-Targeted Omega-3s
Emerging research suggests that individuals experiencing cognitive strain, brain fog, mood fluctuations, or age-related memory concerns may benefit from targeted DHA delivery. Adults managing chronic inflammatory conditions may also find value in supporting inflammation resolution pathways.
For communities seeking evidence-based, patient-centered care, such as those served by multispecialty medical group,s understanding the difference between standard fish oil and brain-targeted omega-3 formulations can support more informed conversations between patients and providers. Rather than viewing fish oil supplementation as one-size-fits-all, evolving lipid science suggests a more nuanced approach.
The Shift From Quantity to Quality
Traditional fish oil remains a well-established supplement for cardiovascular support. However, when the goal shifts specifically toward brain health, delivery form appears to matter as much as, if not more than, total dose. The discovery of the Mfsd2A transporter and the role of LPC-bound DHA has introduced a new chapter in omega-3 science. By designing formulations that align with the brain’s natural transport mechanisms, companies such as Fenix Health Science are contributing to an evolution in how omega-3 supplementation is approached. This conversation may no longer be simply about taking more fish oil for adults seeking to support cognitive health across the lifespan. It prioritizes formulations designed to reach the brain more efficiently, an important distinction in the ongoing pursuit of preventive, evidence-based care.
Conclusion
Omega-3 fatty acids have long held a respected place in preventive health conversations, particularly for cardiovascular support. Yet as research into brain function and aging continues to evolve, it has become increasingly clear that not all omega-3 supplements function in the same way. While traditional fish oil provides EPA and DHA in triglyceride form, newer insights into lipid transport (particularly the role of the Mfsd2A transporter) suggest that the delivery mechanism plays a meaningful role in how effectively these nutrients reach brain tissue.
Fenix Health Science’s LYSOVETA® represents a shift toward targeted, LPC-bound omega-3 delivery designed to align with the brain’s natural transport mechanisms. For adults seeking evidence-based strategies to support cognitive health, the focus may be moving from simply taking more fish oil to choosing formulations designed for more effective brain uptake.
About the Author
